Global Blood Therapeutics, Inc. (GBT)

1 member of Congress has disclosed 4 trades in Global Blood Therapeutics, Inc. (GBT) via STOCK Act filings. The most recent disclosure was a sale by Donna E. Shalala on 24 June 2019. Aggregate disclosed activity totals roughly $16K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for GBT
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for GBT

4 transactions
Compliance: 50%
Donna E. Shalala24 Jun 201927 Apr 2020SaleStock$1,001 - $15,000N/A
Donna E. Shalala24 Jun 201921 Jul 2020SaleStock$1,001 - $15,000N/A
Donna E. Shalala4 Jun 201927 Apr 2020PurchaseStock$1,001 - $15,000N/A
Donna E. Shalala4 Jun 201921 Jul 2020PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$0

Volume

3.28M

Beta

0.46

P/E Ratio

-14.08

Fundamentals

EPS

$-4.86

Div. Yield

-

Open

$68.48

Day Range

$68.47 – $68.49

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Ted Love
IPO Date
2015-08-12
Website
www.gbt.com

Global Blood Therapeutics, Inc. (GBT) is a biopharmaceutical firm dedicated to discovering, developing, and providing therapies for patients suffering from sickle cell disease (SCD) who currently lack adequate treatment options. Its marketed product,...

Earnings

Recent Quarters

Q3 20222 Nov
EPS-
Q2 20228 Aug
EPS$-1.26
Miss 6.8%
Q1 20224 May
EPS$-1.26
Beat 3.1%
Q4 202123 Feb
EPS$-1.36
Miss 20.4%
Q3 20214 Nov
EPS$-1.13
Miss 1.8%
Q2 20213 Aug
EPS$-1.12
Beat 5.9%
Q1 20215 May
EPS$-1.21
Miss 19.8%
Q4 202024 Feb
EPS$-1.00
Miss 6.4%
Q3 20205 Nov
EPS$-0.97
Miss 27.6%
Q2 20205 Aug
EPS$-0.86
Beat 25.2%
Q1 20206 May
EPS$-1.20
Beat 20.5%
Q4 201926 Feb
EPS$-1.59
Miss 28.2%
Q3 20197 Nov
EPS$-1.07
Miss 1.9%
Q2 20197 Aug
EPS$-1.01
Miss 5.2%
Q1 20198 May
EPS$-0.87
Beat 7.5%
Q4 201827 Feb
EPS$-0.93
Miss 4.5%
Q3 20186 Nov
EPS$-0.83
Beat 3.5%
Q2 20182 Aug
EPS$-0.78
Beat 11.4%
Q1 20187 May
EPS$-0.87
Beat 4.4%
Q4 201727 Feb
EPS$-0.94
Miss 32.4%
Q3 20172 Nov
EPS$-0.66
Miss 8.2%
Q2 20177 Aug
EPS$-0.55
Beat 9.8%
Q1 20171 May
EPS$-0.60
Beat 14.3%
Q4 201613 Mar
EPS$-0.74
Miss 17.5%
Q3 20169 Nov
EPS$-0.58
Beat 0.0%
Q2 201610 Aug
EPS$-0.58
Beat 1.7%
Q1 201612 May
EPS$-0.56
Miss 9.8%
Q3 201531 Dec
EPS$-0.53
Q3 201512 Nov
EPS$-0.90
Miss 52.5%
Q2 201524 Sept
EPS$-4.84
Miss 102.5%
Q4 201431 Mar
EPS$-0.34
Q3 201431 Dec
EPS$-0.24
Q2 201430 Sept
EPS$-0.24
Q1 201430 Jun
EPS$-0.24
Q4 201331 Mar
EPS$-0.23

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about GBT

Which members of Congress have traded GBT?
1 member of Congress has disclosed 4 trade in Global Blood Therapeutics, Inc. (GBT) under the STOCK Act: Donna E. Shalala.
When was GBT most recently disclosed by Congress?
The most recent GBT disclosure was a sale by Donna E. Shalala on 24 June 2019.
What is the total disclosed congressional trading volume for GBT?
Members of Congress have disclosed approximately $16K in GBT purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in GBT?
This GBT page updates as soon as new STOCK Act disclosures are filed for Global Blood Therapeutics, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.